Business Description
Hemostemix Inc
NAICS : 325410
SIC : 3741
ISIN : CA4236941080
Description
Hemostemix Inc is a clinical-stage biotechnology company whose principal business is to develop, manufacture, and commercialize blood-derived stem cell therapies for medical conditions not adequately addressed by current treatments. Its product ACP-01 is derived from a patient's own blood and evaluated in clinical research for ischemic conditions, including Cardiovascular Ischemia, Peripheral Arterial Disease (PAD), Chronic Limb Threatening Ischemia (CLTI), and Vascular Dementia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | -12.88 | |||||
Debt-to-Equity | -0.66 | |||||
Debt-to-EBITDA | -0.94 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 25.5 | |||||
3-Year EPS without NRI Growth Rate | 21 | |||||
3-Year FCF Growth Rate | 31.5 | |||||
3-Year Book Growth Rate | 34.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.47 | |||||
9-Day RSI | 36.14 | |||||
14-Day RSI | 37.65 | |||||
3-1 Month Momentum % | -19.06 | |||||
6-1 Month Momentum % | -41.9 | |||||
12-1 Month Momentum % | -64.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.24 | |||||
Quick Ratio | 0.24 | |||||
Cash Ratio | 0.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.1 | |||||
Shareholder Yield % | -39.32 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -442.51 | |||||
ROIC % | -7809.66 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -3.77 | |||||
EV-to-EBITDA | -3.77 | |||||
EV-to-FCF | -2.56 | |||||
Earnings Yield (Greenblatt) % | -26.53 | |||||
FCF Yield % | -50.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HMTXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hemostemix Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.018 | ||
| Beta | 1.1878 | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.55 | ||
| Volatility % | 27.95 | ||
| 14-Day RSI | 37.65 | ||
| 14-Day ATR ($) | 0.000508 | ||
| 20-Day SMA ($) | 0.03868 | ||
| 12-1 Month Momentum % | -64.81 | ||
| 52-Week Range ($) | 0.035 - 0.11 | ||
| Shares Outstanding (Mil) | 205 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hemostemix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hemostemix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.05:1 Stock Split | 2020-12-30 | 0.30 (+0.00%) |
Show
Entries
Hemostemix Inc Frequently Asked Questions
What is Hemostemix Inc(HMTXF)'s stock price today?
The current price of HMTXF is $0.04. The 52 week high of HMTXF is $0.11 and 52 week low is $0.04.
When is next earnings date of Hemostemix Inc(HMTXF)?
The next earnings date of Hemostemix Inc(HMTXF) is .
Does Hemostemix Inc(HMTXF) pay dividends? If so, how much?
Hemostemix Inc(HMTXF) does not pay dividend.
Guru Commentaries on OTCPK:HMTXF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hemostemix Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers